000			01840 a2200529 4500
005			20250518044927.0
264		0	_c20191104
008			201911s 0 0 eng d
022			_a1768-3254
024	7		_a10.1016/j.ejmech.2019.06.037 _2doi
040			_aNLM _beng _cNLM
100	1		_aChen, Shulun
245	0	0	_aDesign, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors. _h[electronic resource]
260			_bEuropean journal of medicinal chemistry _cOct 2019
300			_a38-55 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAmines _xchemical synthesis
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xchemical synthesis
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Design
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aEnzyme Inhibitors _xchemical synthesis
650	0	4	_aFemale
650	0	4	_aHEK293 Cells
650	0	4	_aHumans
650	0	4	_aIndoleamine-Pyrrole 2,3,-Dioxygenase _xantagonists & inhibitors
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMolecular Structure
650	0	4	_aOxadiazoles _xchemical synthesis
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aStructure-Activity Relationship
700	1		_aGuo, Wei
700	1		_aLiu, Xiaohua
700	1		_aSun, Pu
700	1		_aWang, Yi
700	1		_aDing, Chunyong
700	1		_aMeng, Linghua
700	1		_aZhang, Ao
773	0		_tEuropean journal of medicinal chemistry _gvol. 179 _gp. 38-55
856	4	0	_uhttps://doi.org/10.1016/j.ejmech.2019.06.037 _zAvailable from publisher's website
999			_c29830693 _d29830693